Health Company Secures Manufacturing Agreement For 700,000 Units

Cosmos Health Inc., a diversified, vertically integrated global healthcare group, has made strides in expanding its contract manufacturing capabilities through its wholly-owned subsidiary, Cana Laboratories. The company recently announced a new agreement with Provident Pharmaceuticals, securing additional orders that increase their overall order book to 5.02 million units. This development supports Cosmos Health's ongoing efforts to scale up its manufacturing operations and solidify its position within the healthcare industry. $Cosmos Health (COSM.US)$